Spruce Biosciences names medical affairs VP ahead of drug review

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Spruce Biosciences names medical affairs VP ahead of drug review
(NASDAQ: SPRB) Delayed: 53.05 -0.81 (1.5%)
Previous Close $53.86    52 Week High $ 
Open $53.04    52 Week Low $ 
Day High $53.86    P/E N/A 
Day Low $51.80    EPS $ 
Volume 99,661